Active Ingredient: RASAGILINE MESYLATE
Proprietary Name: RASAGILINE MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 0.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A201942
Product Number: 001
Approval Date: Nov 18, 2021
Applicant Holder Full Name: CARNEGIE PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information